Mendelian Reports High Cost of Rare Disease Patients
New research commissioned by health tech company Mendelian found that rare disease patients have cost NHS England in excess of £4.3bn over the past ten years. The company is hoping its technology can enable physicians and hospitals to save money and diagnose patients faster.
You may also be interested in...
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.
At the OurCrowd Global Investor Summit, in Jerusalem, Israel, on 13 February, Medtech Insight met with start-up Sweetch, which has developed a personalized digital health coach for wellness and disease management.
Medtech Insight attended the OurCrowd Global Investor Summit in Jerusalem, Israel on February 13. At the meeting, Ofer Barnea, CEO of neurosurgery start-up SynCath Neuroscience, explained his company’s device to treat cerebral edema,